Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
Status:
Terminated
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess and compare the safety of continuous and daily
subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no planned
vascular interventional procedures; and to determine the effect of Remodulin on wound healing
and treadmill walk distance.